FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
FENTANYL 1000MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
Data Explorer
Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.
Recall totals
All FDA and USDA recalls in Public Health Trace, June 2012 to November 2026.
37,449
Total recall recordsAll FDA and USDA recalls in Public Health Trace9,872
Class I recallsReasonable probability of serious health consequences24,509
Class II recallsTemporary or medically reversible health consequences2,932
Class III recallsNot likely to cause adverse health consequencesQuick insights
A snapshot of the most notable patterns across all recorded FDA and USDA recalls.
Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap.
53 recalls
Most common hazardLack of Assurance of Sterility
2,096 recalls
Newest recallhttps://www.fsis.usda.gov/recalls-alerts/fsis-issues-public-health-alert-meat-and-poultry-products-due-misbranding-andPublished November 6, 2026
Download matching recalls as CSV
CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.
Filters
Metric
View
A chart of recalls grouped by month.
Download CSVSummary (Year to date)
- 1,956 recalls have been announced year to date.
- Oct 2026 was 4% higher than the previous complete period (Sep 2026: 209).
- The highest complete period was Jun 2026 (300).
- Nov 2026 is incomplete and not included in the figures above.
- Complete data
- Incomplete
A bar chart of the total number of recalls in this dataset by recall class.
| Class | Recalls |
|---|---|
| Class II | 24,509 |
| Class I | 9,872 |
| Class III | 2,932 |
| Not Yet Classified | 2 |
| Class | Recalls |
|---|---|
| Class II | 24,509 |
| Class I | 9,872 |
| Class III | 2,932 |
| Not Yet Classified | 2 |
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BUP 9MG/ HYDROM 25MG/ SUF 110MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BUP 5MG/HYDROM 5MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BUP 5.3MG/ FENT 1050 MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BUP 35MG/MORP 10MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BUP 21MG/CLON 252MCG/MORP 20MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BUP 20MG/CLON 250MCG/FENT 7200MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BUP 10MG/HYDROM 15MG/SUF 200MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BUP 10MG/ FENT 1000MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BACLOFEN 2000MCG/ML (40) INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BAC 800MCG/BUP 6.7MG/CLON 600 MCG/FENT 850MCG/MORP 20MG INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BAC 250MCG/ /FENT 3500MCG/ /MORP 25MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BAC 2400MCG/ FENT 2600MCG/ MORP 3600MCG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 27, 2021Historical recordClass II
BAC 160MCG/HYDROM 16MG/ML INJ in 20 mL syringe Assurance Infusion (713) 533-8800
- Reason
- Lack of sterility assurance.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: July 14, 2021Historical recordClass II
Dutasteride Capsules, 0.5 mg, 30 Capsules (6 X 5) Unit Dose per carton, Rx Only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-282-13.
- Reason
- Failed Impurities/Degradation Specifications: High out of specification results for related compounds.
- Published
- January 22, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: September 28, 2022Historical recordClass III
SURE 48hr Confidence Unscented Original Solid Anti-Perspirant & Deodorant Net Wt 2.7 oz (76g) NDC# 41595-5513-2 UPC 8 83484 71794 3 Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912
- Reason
- Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.
- Published
- January 15, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: September 28, 2022Historical recordClass III
SURE 48hr Confidence Regular Original Solid Anti-Perspirant & Deodorant Net Wt 2.7 oz (76g) NDC# 41595-5514-1 UPC 8 83484 717936 6 Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912
- Reason
- Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.
- Published
- January 15, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: September 28, 2022Historical recordClass III
SURE 48hr Confidence Nourishing Coconut invisible solid Antiperspirant & Deodorant Net Wt 2.6 oz (73g) NDC# 41595-5547-1 UPC 8 83484 31020 5 Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912
- Reason
- Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.
- Published
- January 15, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: September 28, 2022Historical recordClass III
SURE 48 hr Confidence Unscented invisible solid Anti-Perspirant & Deodorant, Net Wt. 2.6 oz (73g) NDC# 41595-5509-2 UPC 8 83484 71717 2 Made in Canada and Distributed by Idelle Labs, Ltd., El Paso, TX 79912
- Reason
- Labeling Product Contains Undeclared API: Active Ingredient on label is not the active ingredient in the product.
- Published
- January 15, 2020
- Distribution
- Nationwide
FDA Recall TerminatedTerminated: October 22, 2020Historical recordClass II
Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fumarate tablets 75mg), Rx Only, Distributed by: Lupin Pharmaceuticals Inc Baltimore, MD 21202, Manufactured for: Lupin Limited Pithampur 454775 INDIA 240875, NDC 68180-866-11
- Reason
- Failed Tablet/Capsule Specifications: Complaints related to crumbling of tablets when popped out of the blister pack.
- Published
- January 15, 2020
- Distribution
- Nationwide
Data last updated:
Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.